C. D. Stratton

Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus.

M. Wilson, D. Ortwine, B. Roth, 1990, Journal of medicinal chemistry.

Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus.

C J Blankley, C. J. Blankley, D. Ortwine, 1991, Journal of medicinal chemistry.

Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.

A. Holmes, M. Hoefle, R. F. Meyer, 1975, Journal of medicinal chemistry.

Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.

R. F. Meyer, S. Hastings, C. D. Stratton, 1973, Journal of medicinal chemistry.

Some Compounds Related to Chloromycetin1

C. D. Stratton, M. Rebstock, 1955 .

Compounds Related to Chloromycetin.11-Biphenylyl and Ring-substituted 1-Biphenylyl-2-dichloroacetamido-1,3-propanediols

C. D. Stratton, M. Rebstock, L. L. Bambas, 1955 .